SeraCare Licenses Genetic Testing Controls for CF | GenomeWeb
NEW YORK (GenomeWeb News) – SeraCare Life Sciences today said that it has licensed from Sacred Heart Medical Center & Children’s Hospital in Spokane, Wash., exclusive rights to controls for genetic testing including screening for cystic fibrosis and for diseases common among Ashkenazi Jews.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.